# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Resp...
Redburn Atlantic analyst Ed Ridley-Day initiates coverage on Lantheus Holdings (NASDAQ:LNTH) with a Buy rating and announces...
Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...
JMP Securities analyst David Turkaly maintains Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform and lowers the price...
Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target ...
Full Year 2024 Financial Guidance Guidance Issued July 31, 2024 Guidance Issued May 2, 2024 FY 2024 ...
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.80 per share which missed the analyst consensus estimate of $...
B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target fr...
Jones Trading analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and raises the price target from $12...